Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cordyceps cicadae extract is a medicinal preparation derived from the fungus Cordyceps cicadae, traditionally used in Chinese medicine. It contains bioactive compounds including polysaccharides (62.7 mg/g), alditols (mainly mannitol, 110 mg/g), nucleosides (8.26 mg/g), protein (35.7 mg/g), and polyphenols (3.8 mg/g). A key active component is N6-(2-hydroxyethyl)-adenosine (HEA), present in higher concentrations in the water extract (3.9 mg/g). The extract demonstrates antioxidant properties, promotes hyaluronan synthesis in skin fibroblasts, reduces intraocular pressure, and shows potential benefits for eye conditions including glaucoma, cataracts, and dry eye disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cordyceps cicadae extract.